IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)Research in Context
Victor J. van den Berg,
Dorian O. Haskard,
Artur Fedorowski,
Adam Hartley,
Isabella Kardys,
Mikhail Caga-Anan,
K. Martijn Akkerhuis,
Rohit M. Oemrawsingh,
Robert Jan van Geuns,
Peter de Jaegere,
Nicolas van Mieghem,
Evelyn Regar,
Jurgen M.R. Ligthart,
Victor A.W.M. Umans,
Patrick W. Serruys,
Olle Melander,
Eric Boersma,
Ramzi Y. Khamis
Affiliations
Victor J. van den Berg
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; Department of Cardiology, Northwest Clinics, Alkmaar, The Netherlands; Netherlands Heart Institute (NHI), Utrecht, The Netherlands
Dorian O. Haskard
National Heart and Lung Institute, Imperial College, London, United Kingdom
Artur Fedorowski
Department of Clinical Sciences, Malmö, Lund University, Clinical Research Center, Malmö, Sweden; Department of Cardiology, Skåne University Hospital, Malmö, Sweden
Adam Hartley
National Heart and Lung Institute, Imperial College, London, United Kingdom
Isabella Kardys
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Mikhail Caga-Anan
National Heart and Lung Institute, Imperial College, London, United Kingdom
K. Martijn Akkerhuis
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Rohit M. Oemrawsingh
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Robert Jan van Geuns
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Peter de Jaegere
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Nicolas van Mieghem
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Evelyn Regar
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Jurgen M.R. Ligthart
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Victor A.W.M. Umans
Department of Cardiology, Northwest Clinics, Alkmaar, The Netherlands
Patrick W. Serruys
National Heart and Lung Institute, Imperial College, London, United Kingdom
Olle Melander
Department of Clinical Sciences, Malmö, Lund University, Clinical Research Center, Malmö, Sweden
Eric Boersma
Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
Ramzi Y. Khamis
National Heart and Lung Institute, Imperial College, London, United Kingdom; Corresponding author at: National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0HN, United Kingdom.
Background: Certain immunoglobulins (Ig) are proposed to have protective functions in atherosclerosis. Objectives: We tested whether serum levels of IgG and IgM autoantibodies against malondialdehyde low density lipoprotein (MDA-LDL) are associated with clinical coronary heart disease (CHD) and unfavorable plaque characteristics. Methods: NORDIL was a prospective study investigating adverse cardiovascular outcomes in hypertensive patients. IBIS-3 analyzed lesions in a non-culprit coronary artery with <50% stenosis using radiofrequency intravascular ultrasound (RF-IVUS) and near-infrared spectroscopy (NIRS). Imaging was repeated after a median of 386 days on rosuvastatin. Associations of antibodies with incident CHD and imaging parameters were assessed in the two sub-studies respectively. Findings: From 10,881 NORDIL patients, 87 had serum sampled at baseline and developed CHD over 4.5 years, matched to 227 controls. Higher titers of IgM anti-MDA-LDL had a protective effect on adverse outcomes, with odds ratio 0.29 (0.11, 0.76; p = 0.012; p = 0.016 for trend). Therefore, the effect was explored at the lesional level in IBIS-3. 143 patients had blood samples and RF-IVUS measurements available, and NIRS was performed in 90 of these. At baseline, IgM anti-MDA-LDL levels had a strong independent inverse relationship with lesional necrotic core volume (p = 0.027) and percentage of plaque occupied by necrotic core (p = 0.011), as well as lipid core burden index (p = 0.024) in the worst 4 mm segment. Interpretation: Our study supports the hypothesis that lower circulating levels of IgM anti-MDA-LDL are associated with clinical CHD development, and for the first time relates these findings to atherosclerotic plaque characteristics that are linked to vulnerability. Keywords: Necrotic core, Lipid core, Oxidized low density lipoprotein, Immunoglobulins, Near-infrared spectroscopy, Intravascular ultrasound